Final Programme

myESR.org
Scientific Sessions
10:30 - 12:00 Room N/O
Contrast Media
SS 206
New contrast agents and adverse events
Moderators:
E. Konen; Tel Hashomer/IL
U. Nyman; Trelleborg/SE
B-091 10:30
Water-equivalent oral contrast agents in dual-modality PET/CT scanning: Does a little barium make
the difference?
S. Kinner1 , P. Veit2 , T.C. Lauenstein3 , A. Bockisch1 , G. Antoch1 ; 1Essen/DE, 2Zurich/CH, 3Atlanta, GA/US
B-092 10:39
Ultrasound contrast agents to detect sentinel nods in a pig model: Infl uence of distance from
injection site
K.R. Nielsen, M.B. Nielsen, H. Grossjohan, C.P. Hansen; Copenhagen/DK
B-093 10:48
Contrast enhancement of gadolinium chelates at various fi eld strengths
H.-J. Weinmann, M. Rohrer, H. Bauer; Berlin/DE
B-094 10:57
Gadovist® 1.0M: Tolerance and clinical safety
M. Forsting; Essen/DE
B-095 11:06
Immediate allergic reactions to contrast media: The CIRTACI study, a prospective multicenter
exploration network
O. Clément1 , D. Laroche2 , C. Mouton-Faivre3 , A.-S. Jehenne1 , M. Ouezzani1 , P. Dewachter1 ; 1Paris/FR, 2 3 Caen/FR, Nancy/FR
B-096 11:15
Results from skin testing of 179 patients with contrast media hypersensitivity - a European
multicenter study
K. Brockow1 , C. Christiansen2 , P. Demoly3 , A. Romano4 , W. Aberer5 , A. Bircher6 , A. Barbaud7 , G. Kanny7 ,
W.J. Pichler8 , P. Bonadonna9 , M. Lerch8 , J. Rodrigues Cernadas10 , E. Tomaz11 , J. Ring1 ; 1Munich/DE, 2Oslo/NO, 3 4 5 6 7 8 9 10 11 Montpellier/FR, Troina/IT, Graz/AT, Basle/CH, Nancy/FR, Berne/CH, Verona/IT, Porto/PT, Setúbal/PT
B-097 11:24
Contrast-induced nephropathy in patients with chronic kidney disease: A randomized, double-blind
comparison of iopamidol and iodixanol
H.S. Thomsen1 , B.J. Barrett2 , R.W. Katzberg3 , D.V. Sahani4 , G. Soulez5 ; 1Herlev/DK, 2St. John’s, NF/CA,
3 4 5 Sacramento, CA/US, Boston, MA/US, Montreal, QC/CA
B-098 11:33
The cardiac angiography in renally impaired patients (CARE) study: A randomized, double-blind trial
of contrast-induced nephropathy (CIN) in high-risk patients
R. Solomon1 , M.K. Natarajan2 , S. Doucet3 , S.K. Sharma4 , C.S. Staniloae4 , R.E. Katholi5 , J.L. Gelormini6 ,
M. Labinaz7 , A.E. Moreyra8 ; 1Burlington, VT/US, 2Hamilton, ON/CA, 3Montreal, QC/CA, 4New York, NY/US,
5 6 7 8 Springfi eld, IL/US, Buffalo, NY/US, Ottawa, ON/CA, New Brunswick, NJ/US
B-099 11:42
Are gadolinium contrast agents a possible trigger for the development of nephrogenic fi brosing
dermopathy?
M. Sieber, H. Pietsch, J. Walter, H.J. Weinmann; Berlin/DE
A B C D 267
Friday